Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AZD-9829 by AstraZeneca for Myelodysplastic Syndrome: Likelihood of Approval
AZD-9829 is under clinical development by AstraZeneca and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase II...
AZD-9829 by AstraZeneca for Refractory Acute Myeloid Leukemia: Likelihood of Approval
AZD-9829 is under clinical development by AstraZeneca and currently in Phase II for Refractory Acute Myeloid Leukemia. According to GlobalData,...
AZD-9829 by AstraZeneca for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
AZD-9829 is under clinical development by AstraZeneca and currently in Phase II for Relapsed Acute Myeloid Leukemia. According to GlobalData,...
AZD-9829 by AstraZeneca for Hematological Tumor: Likelihood of Approval
AZD-9829 is under clinical development by AstraZeneca and currently in Phase II for Hematological Tumor. According to GlobalData, Phase II...